RxDoctor Payments Data

Wanda Calvin, MD

Family Medicine · Louisville, KYNPI 1326467358

Payments from drug & device makers

$1,171in general payments, 2019–2025

Across 89 payments — averaging $13.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$217
  • Pfizer$155
  • Merck$134
  • Novo Nordisk$132
  • Amgen$126
  • Eisai Inc.$65
  • plus $342 from 11 others

What the payments were for

  • Food & beverage$1,15198%
  • Education$202%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,171 in reported general payments places this provider in the 60th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$149,295
Medicare patients
345
Services billed
1,738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$101,292
JardianceEmpagliflozin60$78,850
EliquisApixaban78$76,687
JanuviaSitagliptin Phosphate46$51,774
TrulicityDulaglutide27$40,917
Janumet XrSitagliptin Phos/Metformin Hcl14$23,340
XareltoRivaroxaban21$21,585
MyrbetriqMirabegron16$10,670
LinzessLinaclotide15$9,606
Breo ElliptaFluticasone/Vilanterol17$6,768
Atorvastatin Calcium656$6,147
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,120
Nebivolol Hcl47$4,170
Levothyroxine Sodium342$3,605
Bupropion XlBupropion Hcl140$3,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$132$101,29264 claims
Boehringer IngelheimJardiance$23$78,85060 claims
PfizerEliquis$155$76,68778 claims
MerckJanuvia, Janumet Xr$134$75,11360 claims
Lilly USA, LLCTrulicity$60$40,91727 claims
AbbVieLinzess, Synthroid$45$12,290105 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →